Tag: Lancet

When Noncommunicable Diseases Overtook the World: Where We Stand Today and a Peek into the Future #NCDs #Lancet

Probability of dying from a non communicable disease: Change between 2010 and 2020, worldwide For much of human history, infectious diseases, maternal and neonatal conditions, and nutritional deficiencies defined the leading edge of mortality. Plagues, diarrheal disease, and tuberculosis were the archetypal killers. By contrast, noncommunicable diseases (NCDs)—heart disease, cancer, diabetes, chronic lung disease—were rare,... Continue Reading →

0

Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomized controlled study

Background Two randomised controlled trials (RCTs) have previously shown that telemedical monitoring of diabetic foot ulcer (DFU) reduces the number of visits to the outpatient clinic, without losing treatment efficacy or increasing costs. Here we present the results of an open-label, randomised controlled trial designed to investigate whether telemonitoring, provided by an expert nurse (with... Continue Reading →

0

BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients @VascularNews

In the BASIL-2 (Bypass versus angioplasty for severe ischaemia of the leg) trial of 345 patients with chronic limb-threatening ischaemia (CLTI), a best endovascular treatment-first revascularisation strategy was associated with better amputation-free survival than a vein bypass-first strategy in those who required an infrapopliteal repair—with or without a more proximal infrainguinal procedure. This result was... Continue Reading →

0

Up ↑

Verified by MonsterInsights